Texas inmates sue, allege use of expired drugs risks prolonged executions
Two Texas death row inmates sued over use of expired lethal injection drugs for executions.
Why it matters: Why it matters: The lawsuit spotlights constitutional issues about cruel and unusual punishment and demands transparency in execution drug protocols, key concerns for legal professionals monitoring death penalty practices.
- Robert Fratta and John Balentine filed lawsuits challenging Texas' use of pentobarbital vials expired over 20 and 43 months, respectively.
- They sought court orders halting use of the expired drugs and access to unredacted drug testing and inventory records from Texas Department of Criminal Justice (TDCJ).
- The Texas Court of Criminal Appeals denied their appeals, allowing executions to proceed on January 10 and February 8, 2023.
- The case raises questions about statutory compliance, drug testing transparency, and potential constitutional violations in lethal injection procedures.
Two inmates sentenced to death in Texas, Robert Fratta and John Balentine, filed legal actions alleging the state planned to use expired pentobarbital to carry out their executions. Pentobarbital, a barbiturate used to induce unconsciousness in lethal injections, was supplied in 50ml vials expired by more than 20 months for Fratta and 100ml vials expired over 43 months for Balentine. They claimed these expired drugs risked causing painful, prolonged death due to possible failure or obstruction in the intravenous injection process.
In their lawsuits, the inmates sought injunctions to prevent use of the expired drugs. They also demanded that the Texas Department of Criminal Justice (TDCJ) disclose comprehensive, unredacted documentation about the drug inventory and testing results. This information is crucial since TDCJ tightly controls execution drug protocols, and public knowledge about quality testing or expiration handling is minimal.
The lawsuits cited potential statutory noncompliance with procurement and storage regulations for pharmaceuticals and invoked the Eighth Amendment, which prohibits cruel and unusual punishment. The inmates argued that using expired pentobarbital could lead to unconstitutional suffering if executions are delayed or compromised by ineffective drugs.
Despite these arguments, the Texas Court of Criminal Appeals rejected appeals to halt the executions, ruling that the inmates had not demonstrated sufficient risk to prevent the scheduled lethal injections. Fratta was executed on January 10, 2023, followed by Balentine on February 8, 2023.
This case intensifies ongoing debate over the opacity of lethal injection drug sourcing and testing. Without public access to detailed testing data or procurement documents, independent verification of drug quality is challenging. Legal experts note that expired drugs, especially pentobarbital, may degrade or precipitate, potentially causing IV blockages or erratic pharmacological effects during execution.
The case highlights legal tensions between state execution protocols and constitutional safeguards. It underscores the need for greater transparency and regulatory oversight to address ethical concerns about administering the death penalty with aged or unverified chemicals.
By the numbers:
- 20+ months — expiration period on 50ml pentobarbital vials used for Fratta's execution
- 43+ months — expiration period on 100ml pentobarbital vials used for Balentine's execution
- January 10, 2023 — Robert Fratta’s execution date
- February 8, 2023 — John Balentine’s execution date
Yes, but: While the Court of Criminal Appeals allowed the executions to proceed, critics argue the ruling insufficiently addresses potential Eighth Amendment risks arising from expired drugs, leaving ethical and legal questions unresolved.
What's next: There are currently no publicly announced appeals or legislative proposals addressing execution drug transparency or expiration standards in Texas.